ES2054734T3 - Aminoacidos y peptidos glicosilados. - Google Patents

Aminoacidos y peptidos glicosilados.

Info

Publication number
ES2054734T3
ES2054734T3 ES88108485T ES88108485T ES2054734T3 ES 2054734 T3 ES2054734 T3 ES 2054734T3 ES 88108485 T ES88108485 T ES 88108485T ES 88108485 T ES88108485 T ES 88108485T ES 2054734 T3 ES2054734 T3 ES 2054734T3
Authority
ES
Spain
Prior art keywords
amino acids
hydrogen
peptides
amino acid
protective group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88108485T
Other languages
English (en)
Inventor
Cenek Dr Kolar
Horst Prof Dr Kessler
Matthias Kottenhahn
Andreas Kling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2054734T3 publication Critical patent/ES2054734T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) EN LA QUE R1, A, X, Y Y W TIENEN EL SIGNIFICADO QUE SE DETALLA EN LA INVENCION. ESTOS COMPUESTOS CONTIENEN COM OMAXIMO 20 AMINOACIDOS. SE DESCRIBE UN PROCEDIMIENTO PARA SU OBTENCION ASI COMO SUS APLICACIONES.
ES88108485T 1987-05-29 1988-05-27 Aminoacidos y peptidos glicosilados. Expired - Lifetime ES2054734T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873718181 DE3718181A1 (de) 1987-05-29 1987-05-29 Glycosylierte aminosaeuren und peptide

Publications (1)

Publication Number Publication Date
ES2054734T3 true ES2054734T3 (es) 1994-08-16

Family

ID=6328723

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88108485T Expired - Lifetime ES2054734T3 (es) 1987-05-29 1988-05-27 Aminoacidos y peptidos glicosilados.

Country Status (6)

Country Link
EP (1) EP0296374B1 (es)
JP (1) JP2833755B2 (es)
AT (1) ATE87939T1 (es)
CA (1) CA1338500C (es)
DE (2) DE3718181A1 (es)
ES (1) ES2054734T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK129293D0 (da) * 1993-11-16 1993-11-16 Carlsberg Lab Carbonhydratholdige forbindelser, der kan binde sig til carbonhydratbindende receptorer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
DE3434039A1 (de) * 1984-09-17 1986-03-27 Behringwerke Ag, 3550 Marburg Glycopeptide, verfahren zu ihrer herstellung und ihre verwendung
DE3436543A1 (de) * 1984-10-05 1986-04-10 Behringwerke Ag, 3550 Marburg Neue glycourethanverbindungen, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
CA1338500C (en) 1996-07-30
JP2833755B2 (ja) 1998-12-09
DE3718181A1 (de) 1988-12-15
EP0296374A3 (en) 1990-08-08
DE3880021D1 (de) 1993-05-13
JPS63297395A (ja) 1988-12-05
EP0296374B1 (de) 1993-04-07
EP0296374A2 (de) 1988-12-28
ATE87939T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
CA2004991A1 (en) Deletion analogues of magainin peptides
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
NO971621L (no) Keratinocyttvekstfaktoranaloger
CA2020663A1 (en) Substitution analogues of magainin peptides
ATE121754T1 (de) Vakzine gegen bordetella.
NO874905D0 (no) Hirudinvariant og fremgangsmaate til dens fremstilling.
MX9102086A (es) Complejos que contienen acidos s(+) fenilalcanos y amino-azucares
AU4704279A (en) Pharmaceutical formulations of prostacyclin
ES2054734T3 (es) Aminoacidos y peptidos glicosilados.
DE69001513D1 (de) Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln.
FI824030A0 (fi) Nya peptider och foerfarande foer deras framstaellning
AU1464488A (en) Human rhinovirus peptides
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
AU560165B2 (en) Chromophoric peptides
ATE162850T1 (de) Phospholipase c inhibitierendes peptid
AU2169088A (en) Thionophosphonates
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
DE69012328D1 (de) Srif-verwandte peptide und deren verwendungen.
TH5761B (th) วิธีการเตรียมชิ้นกล้าสำหรับการเลี้ยงเนื้อเยื่อพืช
IT1241459B (it) Composizioni farmaceutiche per la somministrazione rettale di calcitonina
DK51990A (da) Aprotininhomologer og fremgangsmaade til fremstilling af aprotinin og aprotininhomologer i gaer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 296374

Country of ref document: ES